October 31st 2024
Learn more about the in-depth topics covered in the October 2024 print issue of Dermatology Times.
Motivators like health benefits, altruism, and trust in clinicians enhance participant retention and adherence in melanoma research, according to MEL-SELF findings.
Dermatology Times is looking back on the top stories in dermatology from the month of October.
Dermatology Times is recapping our top expert interviews from the month of October.
October 30th 2024
A pilot study monitored the disease management, technical challenges, and overall benefits for chronic spontaneous urticaria.
Approvals Expand Treatment Options
“This approval reflects our dedication to ensuring high-quality treatments are universally accessible,” Claire D’Abreu-Hayling, chief scientific officer of Sandoz, said in a news release.
AI Scribes Part 1: Reducing Documentation Time and Uncovering New Ethical Challenges in Health Care
Since the first electronic medical record emerged in 1972, clinicians have found themselves increasingly trapped behind screens.
Study Shows AI Offers Mixed Results in Mohs Education
Despite high accuracy scores, the study found AI models often produce overly complex explanations, making them less effective for patient education.
Insights Into the Approval of Denileukin Diftitox-cxdl for Cutaneous T-Cell Lymphoma
Myron Czuczman, MD, of Citius Pharmaceuticals recently shared perspectives on the role and potential of Lymphir in CTCL.
Understanding Dermatological Needs of Gender-Diverse Patients
A recent Australian study reviewed appropriate terminology, gender affirming options, and dermatological considerations in caring for gender-diverse patients.
Comparing AI Models for Dermatological Diagnoses
Researchers emphasized the need for improved reliability and regulatory frameworks for AI tools before they are integrated into dermatological practice.
FDA Approves Denileukin Diftitox for Adults With Relapsed or Refractory Cutaneous T-Cell Lymphoma
The approval is supported by positive phase 3 data for Lymphir in this indication.
Back to School, Back in the Spotlight
Young patients are heading back to school, and common skin issues like acne, eczema, warts, and pigmentation can affect their confidence, Shanna Miranti, MPAS, PA-C, writes.
Women With Skin of Color are Underrepresented in Studies of Treatments for Vulvar Lichen Sclerosus
Topical corticosteroids are the gold standard treatment for VLS, yet women with skin of color are not represented in studies.
From OX40 Inhibition to Pediatric Pearls: Back-to-School Time for Physicians and Patients Alike
Our August issue covers common back-to-school skin conditions, psoriasis research, OX40 inhibition for atopic dermatitis, and pediatric dermatology meeting highlights.
Experts Form Consensus on AI's Role in Aesthetics
A group of international experts focused on the technology’s potential to standardize and enhance patient assessments.
Screening Questionnaire Developed for Type 2 Inflammation Diseases
The 15-piece questionnaire is designed to be quick and easy to use during consultations, with particular benefits across numerous specialties.
Dupilumab Shows Promise as Bullous Pemphigoid Treatment
Researchers stated the drug could avoid the need for additional immunosuppressive treatments associated with increased morbidity and mortality.
Gaps in Post-Inflammatory Hyperpigmentation Research for Skin of Color
PIH, more prominent in darker skin types, often leads to significant psychosocial distress and reduced quality of life.
Dermatology Times July 2024 Recap
Dermatology Times is looking back on the top stories in dermatology from the month of July.
Interview Intersection: Expert Interviews From July 2024
Dermatology Times is recapping our top expert interviews from the month of July.
Sex and Gender Gaps in Dermatology Treatment
A recent review called for gender-specific studies to enhance dermatological treatments and potentially revise guidelines.
Generation Z, Millennials Exhibit Similar Subjective Perception of Atopic Dermatitis Disease Severity
Generation Z patients had lower atopic dermatitis severity but similar disease perception compared to Millennial patients.
SLIDESHOW: Overview of July 2024 FDA Approvals
Take a deep dive into the 3 approvals for various dermatological conditions this month.
Dysmorphic Concern, Body Dysmorphic Disorder More Prevalent in Women with Skin Conditions than Men
Researchers reported gender differences among individuals with skin conditions and compared sociodemographic, clinical and psychological variables.
We are Biologic Coordinators of Dermatology (BCoD)
Explore how BCs are supported through complex drug approvals and ensuring patients have access to prescribed medications.
Electroablation Plus Pharmacotherapy Leads to Reduction in Keloid Volume
Combining electrocoagulation with pharmacotherapy significantly reduced keloid scar volume by inhibiting collagen deposition, angiogenesis, and cell proliferation.
Skin Manifestations More Common Than Internal Organ Involvement in Sjögren Syndrome
A recent study examined skin manifestations and SS from a dermatological perspective.
Study Reports High Frequency of Emergency Complications During Dermatological, Surgical, and Cosmetic Procedures
Researchers noted that many dermatologists face mild, non-life-threatening complications during procedures, yet must be prepared for emergencies.
The Interplay Between Sleep Disorders and Dermatology
A recent review investigated all known information between skin conditions and sleep disorders, finding a bidirectional influence between them.
Derm In The News: July 14-20
Keep up with the latest headlines in dermatology from the past week, including racial disparities in hidradenitis suppurativa, Stanford Medicine's new Skin of Color program, and more.
The Weekly Roundup: July 15-19
In case you missed it, this week we had news about Oleogel-10's potential in dressing changes for pediatric patients with epidermolysis bullosa, data for repigmentation with ruxolitinib cream, a review of pediatric cutaneous Crohn disease, and more.
First Human Trial Shows CBD’s UVA-Protective Benefits
The study saw a reduction of 2 major UVA-induced mtDNA deletions associated with skin photoaging.
TNF Blockade Shows Effectiveness for Pediatric Cutaneous Crohn Disease; Interleukin-12/23 Inhibitors Also Promising
A recent case series reviewed the treatment patterns and effects of therapies on 89 pediatric patients with CCD.
Topical Isotretinoin Shows Promise in Phase 3 ASCEND Trial for Congenital Ichthyosis
TMB-001 0.05% demonstrates promising efficacy and safety in treating moderate to severe congenital ichthyosis, according to a poster presented at the SPD's annual meeting.